Combo Therapy After Stem Cell Transplant Improves Survival in Myeloma Patients, Trial Finds – Myeloma Research News
Myeloma Research News |
Combo Therapy After Stem Cell Transplant Improves Survival in Myeloma Patients, Trial Finds
Myeloma Research News The standard care for younger patients with newly diagnosed myeloma is treatment with high-dose Alkeran (melphalan) followed by a transplant with the patient's own stem cells (autologous stem cell transplant, or ASCT). But most patients relapse after … |
